Malignant otitis externa caused by ciprofloxacin-resistant Pseudomonas aeruginosa

Authors

  • Javier Ena-Muñoz Servicio de Medicina Interna, Hospital Marina Baixa, Villajoyosa (Alicante), Spain
  • Antonio Burgos-Sánchez Servicio de Otorrinolaringología, Hospital Marina Baixa, Villajoyosa (Alicante), Spain

DOI:

https://doi.org/10.32818/reccmi.a3s1a9

Keywords:

diabetes mellitus , malignant otitis externa, ciprofloxacin, Pseudomonas aeruginosa

Abstract

 

Malignant otitis externa is an inflammatory condition caused by Pseudomonas infection of the ear canal with involvement of the temporal bone. It is usually seen in elderly patients with diabetes or patients with immunosuppression. Characteristically the patient presents severe pain and an external canal often edematous, inflammed, and coated with exudate. If the condition is not promptly treated lower cranial nerve palsies can develop due to subtemporal extension of the infection. Treatment consists of prolonged administration (i.e. 6-8 weeks) of an anti-pseudomonal antibiotic (usually oral ciprofloxacin), but recently the emergence of resistant strains have been described.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Pérez P, Ferrer J, Bermell A, Ramírez R, Saiz V, Gisbert J. Otitis externa maligna. Nuestra experiencia. Acta Otorrinolaringol Esp. 2010; 61(6): 437- 440.

Rubin Grandis J, Branstetter BF 4th, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis. 2004; 4: 34-39.

Bernstein JM, Holland NJ, Porter GC, Maw AR. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa. J Laryngol Otol. 2007; 121: 118-123.

Published

2018-01-31

How to Cite

1.
Ena-Muñoz J, Burgos-Sánchez A. Malignant otitis externa caused by ciprofloxacin-resistant Pseudomonas aeruginosa. Rev Esp Casos Clin Med Intern [Internet]. 2018 Jan. 31 [cited 2024 Jul. 22];3:19-21. Available from: https://www.reccmi.com/RECCMI/article/view/231